By BOPA EDI SubCommittee on 3rd February 2023

BOPA Equity, Diversity and Inclusion (EDI) Code of Conduct Policy and Policy Statement

BOPA is committed to building a diverse, equitable and inclusive community for all members, non-members and patients in cancer care.  The British Oncology Pharmacy Association (BOPA) has produced a code…

Read article
By BOPA on 30th January 2023

WFPHA invites all health professionals to fill out this survey

Dear healthcare and public health professionals from UK The World Federation of Public Health Associations (WFPHA), NGO in official relations with the World Health Organisation (WHO), is starting a project…

Read article
By BOPA on 30th January 2023

Electronic Prescribing and Medicines Administration Systems: report adverse incidents on a Yellow Card

We ask healthcare professionals to be vigilant to adverse incidents involving software, apps, and artificial intelligence (AI) as medical devices and to report incidents to us via the Yellow Card…

Read article
By BOPA Committee on 27th January 2023

My Research Webinar – Role of the Pharmacist in Geriatric Oncology

Wednesday 8th February at 19:00 BST     Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/   We would like to invite you to join our  ‘My Research’ sessions. These sessions are…

Read article
By BOPA E&T on 25th January 2023

Recordings Now Available – BOPA E&T and Genomic Webinars

E&T Webinar Series from 2021 are now available as eLearning under the Education Section on the BOPA website: https://www.bopa.org.uk/courses/ New Webinars Available: BOPA E&T Webinar – A Small Oncology Team…

Read article
By BOPA on 24th January 2023

The BOPA-PRUK research award

The BOPA-PRUK research award This award provides pharmacy professionals who are new to research with the extra incentive to get their research career started. Pharmacy Research UK (PRUK) and the…

Read article
By BOPA on 20th January 2023

New logos for the ‘Education & Training’ and ‘My Research’ webinar series

BOPA is delighted to unveil the new logos for the ‘Education & Training’ and ‘My Research’ webinar series.    Both webinar series have been huge successes over the past few years…

Read article
By BOPA on 12th January 2023

[Educational Videos] Genomics Enabling Personalised Treatment for Cancer Patients

The Genomic Medicine Special Interest Group have produced a 3-part primer videos – ‘Genomics Enabling Personalised Treatment for Cancer Patients‘. The videos aim to improve the understanding of some fundamentals…

Read article
By BOPA on 12th January 2023

BOPA Verification Passport Survey for oncology pharmacy staff members

BOPA are currently working on a project to update the verification standards and verification e-learning. As part of this project BOPA are also working on updating and rolling out a…

Read article
By BOPA on 11th January 2023

BOPA E&T x GMSIG – Genomics Webinar Series – REGISTER NOW

The BOPA Education and Training Subcommittee would like to invite you to a series of Genomic Webinars prepared and presented by the BOPA Genomic Medicines Special Interest Group.   Webinar…

Read article
By BOPA on 9th January 2023

Position Statement: BOPA supports the withdrawal of histamine 2 (H2) antagonists from paclitaxel pre-medication regimens following publication of research which demonstrates their lack of effect. January 2023

BOPA is pleased to announce publication of a position statement confirming our support for removal of H2 antagonists from paclitaxel pre-medication regimens. This position statement follows on from the excellent…

Read article
By BOPA on 9th January 2023

Position Statement: Pharmacy Technician Clinical Verification of Systemic Anti-Cancer Therapy (SACT) and Supportive Medication Prescriptions

BOPA is pleased to announce publication of a position statement confirming our support for pharmacy technician verification of SACT and supportive medicines prescription. The BOPA executive committee acknowledges the contribution…

Read article